Skip to main contentSkip to navigation
Sirius Investors

VNTA Financial Statements & Analysis

Complete financial statements for VNTA including income statement, balance sheet, and cash flow statement. Analyze VNTA's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q4 '25TTM Q4 '25ChangeImpact
Revenue114.58K114.58K0.0%
Gross Profit000.0%
Operating Income100.81K100.81K0.0%
Net Income86.14K86.14K0.0%
EPS0.000.000.0%
EBITDA100.81K100.81K0.0%
Gross Margin0.00%0.00%0.0%
Operating Margin87.99%87.99%0.0%
Net Income Margin75.18%75.18%0.0%
R&D Expenses000.0%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q4 '25TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Revenue114.58K114.58K67.66K
Gross Profit000
Operating Income100.81K100.81K50.64K
Net Income86.14K86.14K49.77K
EPS0.000.000.00
EBITDA100.81K100.81K50.64K
Gross Margin0.00%0.00%0.00%
Operating Margin87.99%87.99%74.86%
Net Income Margin75.18%75.18%73.57%
R&D Expenses000

Our detailed financial analysis helps investors understand VNTA's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track VNTA's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into VNTA's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
Ventana Biotech, Inc. (VNTA) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors